# PEMETREXED
> **NDA208419** · New Drug Application · Sponsor: ACTAVIS · Approved 2020-08-21
## Drug
- **FDA Application Number:** NDA208419
- **Application type:** New Drug Application
- **Brand name:** PEMETREXED
- **Generic name:** PEMETREXED
- **Active ingredients:** PEMETREXED
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2020-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208419)
---
*AI Analytics · CC0 1.0*